• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Product Classification

  • Print
  • Share
  • E-mail
-
New Search Back to Search Results
Device transdermal test for assessment of glomerular filtration rate
Definition A test used to assess a patient’s glomerular filtration rate (GFR) by injecting a fluorescent tracer molecule into the blood stream and measuring the amount of fluorescence through the skin with a transdermal sensor.
Physical State The test system may include sensors, software, a monitor, and a molecular tracer agent which is injected into the patient.
Technical Method A tracer is injected into a patient’s blood stream and a sensor is used to measure the tracer signal from the blood through the patient’s skin. This signal is converted to a glomerular filtration rate.
Target Area Kidney or Renal
Review Panel Gastroenterology/Urology
Product CodeSDK
Premarket Review Renal, Gastrointestinal, Obesity and Transplant Devices (DHT3A)
Renal, Gastrointestinal, Obesity and Transplant Devices (DHT3A)
Submission Type PMA
Device Class 3
Total Product Life Cycle (TPLC) TPLC Product Code Report
GMP Exempt? No
Summary Malfunction
Reporting
Ineligible
Implanted Device? No
Life-Sustain/Support Device? No
Third Party Review Not Third Party Eligible
-
-